Treos Bio Announces FDA Approval of IND of Its First PolyPEPI™ Precision Cancer Vaccine for Metastatic Colorectal Cancer
24 janv. 2018 08h15 HE
|
Treos Bio Corp.
SAN FRANCISCO and LONDON, Jan. 24, 2018 (GLOBE NEWSWIRE) -- Treos Bio Limited, an immuno-oncology company developing next-generation, off-the-shelf precision cancer vaccines coupled with companion...
Global Cancer Immunotherapy Market & Clinical Trials Outlook 2022: Download Report, Market Opportunity at USD 100 Billion, Clinical Trial Insight by Drug Class
26 juin 2017 04h12 HE
|
KuicK Research
NEW DELHI, India, June 26, 2017 (GLOBE NEWSWIRE) -- Global Cancer Immunotherapy Market & Clinical Trials Outlook 2022 report highlights: Cancer Immunotherapy Market Assessment by ClassCancer...
Immunophotonics, Inc. Announces First Patient Dosed in a Randomized, Controlled Breast Cancer Clinical Trial for inCVAX – A Novel Investigational Immuno-Oncology Therapy
23 août 2016 09h17 HE
|
ImmunoPhotonics, Inc.
ST. LOUIS, Aug. 23, 2016 (GLOBE NEWSWIRE) -- Immunophotonics today announces that it has dosed its first patient in a randomized & controlled clinical trial to further evaluate the efficacy of...
Intensity Therapeutics Forms Scientific Advisory Board Comprised of World-Leading Oncologists and Scientists
22 oct. 2015 07h35 HE
|
Intensity Therapeutics Inc
Westport, CT, Oct. 22, 2015 (GLOBE NEWSWIRE) -- Intensity Therapeutics, Inc., a privately-held biotechnology company developing proprietary immune cell activating anti-cancer drug products, announced...
MMRGlobal Receives Cancer-Fighting Anti-CD20 Monoclonal Antibodies Patent in Korea
31 janv. 2014 08h35 HE
|
MMRGlobal, Inc.
LOS ANGELES, CA--(Marketwired - Jan 31, 2014) - MMRGlobal, Inc. (OTCQB: MMRF) ("MMR"), a leading provider of Personal Health Records (PHRs), MyEsafeDepositBox storage solutions and electronic...
MMRGlobal Receives Additional Biotech Patent Protection in U.S., Mexico and Japan for Cancer Vaccines
02 oct. 2013 08h35 HE
|
MMRGlobal, Inc.
LOS ANGELES, CA--(Marketwired - Oct 2, 2013) - MMRGlobal, Inc. (OTCQB: MMRF) ("MMR"), a leading provider of Personal Health Records (PHRs), MyEsafeDepositBox storage solutions and electronic...
MMRGlobal Adds Japan & South Korea to China in Filing of Cancer Fighting Patent Under Expedited Patent Allowance Program
26 août 2013 08h35 HE
|
MMRGlobal, Inc.
LOS ANGELES, CA--(Marketwired - Aug 26, 2013) - MMRGlobal, Inc. (OTCQB: MMRF) ("MMR"), a leading provider of Personal Health Records (PHRs), MyEsafeDepositBox storage solutions and electronic...
MMRGlobal Files Additional Cancer Fighting Patent in China Under Expedited Patent Allowance Program
19 août 2013 08h35 HE
|
MMRGlobal, Inc.
LOS ANGELES, CA--(Marketwired - Aug 19, 2013) - MMRGlobal, Inc. (OTCQB: MMRF) ("MMR"), a leading provider of Personal Health Records (PHRs), MyEsafeDepositBox storage solutions and electronic...
MMRGlobal Receives Cancer Fighting Vaccine Patent in Hong Kong
25 juin 2013 08h35 HE
|
MMRGlobal, Inc.
LOS ANGELES, CA--(Marketwired - Jun 25, 2013) - MMRGlobal, Inc. (OTCQB: MMRF) ("MMR") today announced that it has received another biotechnology patent, this one in Hong Kong. The Company has...
Dr. Ivor Royston, Oncologist, Scientist, Entrepreneur-Financier and Founding Father of San Diego Biotech, Joins MMRGlobal Board
28 mai 2013 08h20 HE
|
MMRGlobal, Inc.
LOS ANGELES, CA--(Marketwired - May 28, 2013) - MMRGlobal, Inc. (OTCQB: MMRF) ("MMR" or the "Company") today announced that Ivor Royston, M.D. has agreed to join the Company's Board of Directors...